课题基金 / 基金详情

项目摘要

项目成果

XI LIN的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Connexins (Cxs) are membrane proteins constituting the gap junctions (GJs). The major function of GJs is to provide a regulated conduit for intercellular ionic, electrical and biochemical (e.g., nutrients and signaling molecules) couplings. Genetic studies have linked more than 100 mutations in the Cx26 gene to a large proportion of prelingual nonsyndromic deafness. Despite the importance of GJs in hearing as revealed by genetic studies, we know very little about their functional role in the cochlea. One major reason is the lack of appropriate animal models based on which human hereditary deafness caused by various types of Cx mutations could be studied. Our long-term goal is to understand the function of GJ channels in the cochlea at the molecular level. We hypothesize that the molecular mechanisms underlying pathological changes of large truncation mutations and point mutations of Cx26 are markedly different. We will use genetic engineering techniques to create mouse models that are both informative in revealing the molecular function of cochlear GJs and in helping us understand cochlear pathologies caused by various types of human Cx26 mutations. Using the Cre-loxP mediated conditional gene targeting method, we will create four lines of mouse models representing the following four types of human Cx26 mutations as revealed from in vitro studies: (1) mutations that cause a selective loss of biochemical permeability (e.g., V84L); (2) mutations that alter the Ca++ binding affinity to Cx26 hemichannels, such that hemichannels are leaky at physiological concentrations of Ca++ (e.g., G45E); (3) mutations that cause a selective loss of GJ whole channel functions, but the hemichannel function is largely unchanged (e.g., R75W); (4) total loss of GJ- mediated intercellular communications (e.g., D179N). We will then examine the morphological and functional changes in the cochleae of the four lines of genetically modified mice. The availability of these mouse models will greatly facilitate investigations into the mechanism of the most common form of congenital hearing impairment at the molecular level. The knowledge gained should advance our understanding of the functional roles of GJs in the cochlea as well as help designing treatment strategies for a large portion of hereditary deafness patients. Genetic studies have linked more than 100 mutations in the connexin genes to about half of all cases of prelingual deafness. The focus of this project is to establish appropriate animal models based on which human hereditary deafness caused by various types of Cx mutations could be studied. The availability of these mouse models will greatly facilitate investigations into the mechanism of most common form of congenital hearing impairment at the molecular level. The knowledge gained should help us design better treatment strategies for a large portion of hereditary deafness patients.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bbrc.2009.05.023
发表时间: 2009-07-17
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Wang, Yunfeng, Chang, Qing, Tang, Wenxue, Sun, Yu, Zhou, Binfei, Li, Huawei, Lin, Xi]
通讯作者: Lin, Xi
DOI: 10.1002/cne.22117
发表时间: 2009-10-20
期刊: The Journal of comparative neurology
影响因子: --
作者: [Sun Y, Tang W, Chang Q, Wang Y, Kong W, Lin X]
通讯作者: Lin X
Gene Therapy for Treating Human Genetic Deafness Tested in Animal Models
  • 批准号:
    9030530
  • 项目类别:
  • 资助金额:
    $48.18万
  • 财政年份:
    2016
  • 负责人:
    XI LIN
  • 依托单位:
Gene Therapy for Treating Human Genetic Deafness Tested in Animal Models
  • 批准号:
    9217640
  • 项目类别:
  • 资助金额:
    $48.18万
  • 财政年份:
    2016
  • 负责人:
    XI LIN
  • 依托单位:
D- CHIRO-INOSITOL IS ABSORBED BUT NOT SYNTHESISED IN RODENTS
  • 批准号:
    8361407
  • 项目类别:
  • 资助金额:
    $0.79万
  • 财政年份:
    2011
  • 负责人:
    XI LIN
  • 依托单位:
HUMAN SODIUM/INOSITOL COTRANSPORTER 2 (SMIT2) TRANSPORTS INOSITOLS
  • 批准号:
    8361406
  • 项目类别:
  • 资助金额:
    $0.72万
  • 财政年份:
    2011
  • 负责人:
    XI LIN
  • 依托单位: